NCT05800587View on ClinicalTrials.gov

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

February 22, 2023

Primary Completion Date

August 1, 2028

Study Completion Date

August 1, 2029

Conditions
Lung CancerSmall-cell Lung CancerNon Small Cell Lung Cancer
Interventions
DRUG

Carboplatin

Standard of care chemotherapy regimen

DRUG

Pemetrexed

Standard of care chemotherapy regimen

DRUG

Paclitaxel

Standard of care chemotherapy regimen

DRUG

Nab paclitaxel

Standard of care chemotherapy regimen

DRUG

Docetaxel

Standard of care chemotherapy regimen

DRUG

Gemcitabine

Standard of care chemotherapy regimen

DRUG

Etoposide

Standard of care chemotherapy regimen

DRUG

Irinotecan

Standard of care chemotherapy regimen

DRUG

Topotecan

Standard of care chemotherapy regimen

DRUG

Lurbinectedin

Standard of care chemotherapy regimen

Trial Locations (1)

19111

RECRUITING

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
lead

Fox Chase Cancer Center

OTHER